Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Recruitment completed in uPAR-PET study in brain cancer

Copenhagen, Denmark, 30 June 2022 - Curasight A/S ("Curasight" or the “Company" - TICKER: CURAS) announces today that the investigator-initiated phase II study using uPAR-PET in brain cancer has now completed the inclusion of patientsThe investigator-initiated trial testing [68]Ga-NOTA-AE105 uPAR-PET/MR in patients with gliomas (most common primary brain cancers) aimed to collect data on 30 patients out of a total of 35 patients recruited to the trial. This number has now been reached and the first data analysis can begin according to the primary investigator. The trial, being carried

Keliber’s Lithium Project Progresses with Financing by Sibanye-Stillwater

The future lithium hydroxide producer Keliber Oy, operating in the Central Ostrobothnia area in Finland, has prepared a financing arrangement to enable the Keliber lithium project to progress to the construction phase. The proposed arrangement includes two share issues. In the first one, Sibanye Stillwater Limited will exercise its pre-emptive right to achieve a 50% plus 1 majority shareholding for new Keliber shares to the value of EUR 146 million. The second share issue will have a value of approximately EUR 104 million. In addition, Keliber’s shareholders will receive a Voluntary Offer

Nordic Mining sells Keliber stake for EUR 46.9 million (NOK 483 million)

Nordic Mining ASA (“Nordic Mining” or the “Company”) is pleased to announce that the Company has irrevocable accepted to sell its shares in Keliber Oy (“Keliber”) to Sibanye Stillwater Limited (“SSW”) for a cash consideration of EUR 157.28 per share, in total EUR 46.9 million (NOK 483 million), under a voluntary offer ("Voluntary Offer") provided by SSW to the shareholders of Keliber today. SSW’s offer is made on the basis of an independently calculated fair market value as determined by two leading independent investment banks, Royal Bank of Canada and Bank of Montreal, in May 2022 in

BioStock: Arcede Pharma’s CEO is ready for Spotlight

When BioStock contacts Arcede Pharma’s new CEO Mia Lundblad, the company is just about to be listed for trading on Spotlight Stock Market. We spoke to Mia to find out more about her background; the journey from Astra Hässle, via Novo Nordisk, to a small development company in Lund with ambitions to launch the next generation COPD treatment.Read the full article at biostock.se:https://www.biostock.se/en/2022/06/arcede-pharmas-ceo-is-ready-for-spotlight/This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se

Epiroc wins large surface mining equipment order in Australia

Stockholm, Sweden: Epiroc, a leading productivity partner for the mining and Infrastructure industries, has won a large order for mining equipment from Rio Tinto in Australia.Rio Tinto, one of the world’s largest mining companies, has ordered several Epiroc Pit Viper 271 drill rigs that will be retrofitted by Rio Tinto with autonomous capabilities, as well as SmartROC D65 drill rigs that also are loaded with intelligent features. They will be used in the Pilbara  region of Western Australia, where Rio Tinto is operating a highly

Conclusion of change in the number of shares and votes in Atlas Copco AB

Nacka, Sweden, June 30, 2022: During June 2022, the number of outstanding shares in Atlas Copco AB decreased to 4,918,452,416 from 6,148,065,520 and the number of votes to 3,513,663 987.20 from 4,392,079,984.00.The change is a result of the share split resolved by the Annual General Meeting on April 26, 2022, whereby each share was divided into four (4) ordinary shares and one (1) redemption share, which is now concluded. Following the redemption, there are 3,357,576,384 series A shares and 1,560,876,032 series B shares in the company.Redemption shares resulting from the share split

Q-Free: Thale Kuvås Solberg appointed Chief Executive Officer

(Bergen/Trondheim, 30 June 2022). The Board of Directors of Q-Free ASA (Q-Free, OSE: QFR) today announces the appointment of Thale Kuvås Solberg as Chief Executive Officer (CEO). “We are delighted to announce Thale Kuvås Solberg as the new CEO of Q-Free. Thale brings vast experience and a proven track record on global business development with focus on growth, recurring revenue business models and sustainability. We are confident that Thale, together with the Q-Free executive management team and supported by the Board of Directors, will capitalize on the restructured growth platform to

The PanDIA-1 study, for early detection of pancreatic cancer in newly onset type 2 diabetics, moves into next phase

LUND, SWEDEN – Immunovia today announced the PanDIA-1 study for the early detection of pancreatic cancer in newly onset type 2 diabetics is moving into the next phase. Samples with the associated clinical data have been transferred to Immunovia from Lund University Diabetes Center (LUDC). During the second half of 2022 the samples will be analyzed as the next phase of the development plan for this large risk group.   “We are entering into a decisive phase of the PanDIA study, aiming to give another substantial risk group for pancreatic cancer the ability to get access to early

Mandatory notification of trade

Magdalena Kadziolka, Board member of Otello Corporation ASA, has on behalf of certain related parties, as of 29th June 2022, acquired interests in shares of Otello Corporation ASA. The balance of Magdalena Kadziolka and related parties’ holdings after the transaction totals 28,578,826 shares. Please refer to the attached notification of trading for further details. This information is subject to disclosure requirements in regulation EU 596/2014 article 19 number 3 and the Norwegian Securities Trading Act section 5-12.

Recap Energy installs 3,3 MW energy storage in VänerEnergi grid.

Juni 2022 Large scale battery energy storage systems support the electricity grid in Töreboda and Mariestad. Recap Energy today announced a collaboration with VänerEnergi and Hitachi Energy where Recap installs 3,3 MW battery energy storage solutions (BESS). This collaboration will lift the Recap concept “Battery as a Service” where the client pays for the hourly capacity used from the energy storage. Battery as a Service (BaaS) is a concept that will, amongst other, help clients to reduce peak load problems without taking on heavy investments. A local grid company such

RhoVac provides a status update and investigates a potentially accelerated repayment of the convertible loan

RhoVac AB ("RhoVac"), (June 30[th] 2022) a Swedish company active in cancer immunotherapy, was forced on 29 May 2022 to announce that the company's phase IIb study in prostate cancer, BRaVac, despite the previous positive results related to the substance, failed to show that RV001 (onilcamotide) was superior to placebo in preventing progression in patients with biochemical recurrence (an increase in PSA) after curative intent treatment. Further investigations of study data have been undertaken, but so far nothing of substance has been identified that has a justifiable risk/benefit ratio to

Intends to carry out a guaranteed rights issue of SEK 100 million

Scout Gaming Group AB, “company” or “SGG” informs that the board of directors have taken the decision to call for an Extra General Meeting and make a proposal for a rights issue at the level of SEK 100 million. The share issue will be fully guaranteed by commitments from the shareholders Knutsson Holdings AB, Novobis AB, Scobie Ward and TopLine Capital LLC. The funds from the share issue will in part be used to repay the bridge financing amounting to SEK 40 million which the company has press released today and on May 29[th] of this year and in part concerning other measures which the

BEWI – Sale of industrial real estate portfolio to KMC Properties for NOK 2.0 billion

BEWI ASA, a leading provider of packaging, components, and insulation solutions, has today entered into an agreement with a wholly owned subsidiary of KMC Properties ASA (“KMC Properties”) for the sale of up to 24 properties and one land plot, with a gross asset value of up to approximately NOK 2.0 billion. In connection with the transaction (the “Property Transaction”), long term triple net rental agreements will be entered into for the properties. “This divestment is in line with our strategy and similar to previous transactions, including the divestments in the Netherlands and Denmark

Restructuring and reorganization

Scout Gaming Group AB, ”company” or "SGG" informs that the company are carrying out an extensive change in its organization, bringing about a significant reduction in the number of employees and consultants. At the end of the first quarter of this year SGG had 131 full time employees, after decision made in the company’s Board, the organization will decrease to 63 full time employees. Further a new management group will be formed which besides the CEO will contain management positions for Finance, Sales and Product. The changes are made to create a more streamlined and executive

Bonava acquires approximately 150 building rights in Haninge

Bonava has signed an agreement for the acquisition of four properties totalling 90,000 square metres in Haninge, where Bonava intends to construct approximately 150 Nordic Swan ecolabelled housing units. The seller is a private property developer, and the transaction totals SEK 153 million in underlying property value. Handover of the properties will take place in the third quarter of 2022 and production of the first housing units is expected to begin after a zoning plan is established, at the earliest in 2026.– With this land acquisition, we guarantee future production volume in Haninge, a

Imfinzi improved pCR in resectable lung cancer

30 June 2022 07:00 BST Imfinzi plus chemotherapy significantly improved pathologic complete response in AEGEAN Phase III trial in resectable non-small cell lung cancer Trial will continue to assess additional primary endpoint of event-free survival Positive high-level results from a planned interim analysis of the AEGEAN Phase III trial showed treatment with AstraZeneca's Imfinzi (durvalumab) in combination with neoadjuvant chemotherapy before surgery demonstrated a statistically significant and meaningful improvement in pathologic complete response (pCR) compared to neoadjuvant

New number of shares and votes in Moberg Pharma AB (publ)

STOCKHOLM, June 30[th], 2022, Moberg Pharma AB (OMX: MOB) announced that the total number of common shares in the company has increased to 100,859,335 due to the completion of the previously announced rights issue, the previously announced directed issue to certain guarantors in the rights issue and the previously announced issue of class C shares, which subsequently have been repurchased and converted to common shares, intended to ensure fulfilment of commitments under incentive programmes.During June 2022, the total number of shares and votes in the company has increased by 54,178,212,

Metso Outotec strengthens its MD series with compact-size Low Rider pumps for easy replacements

Metso Outotec Corporation’s press release on June 30, 2022, at 09:00 a.m. EESTMetso Outotec is complementing its MD pump series with compact MD Low Rider pumps designed for easy replacements and upgrades. The new cost-efficient pump range is targeted especially for installations with limited space. “I am happy to see this new addition to our offering of Planet Positive  MD series pumps. With its reduced mechanical footprint, the MD Low Rider is a perfect replacement for any pump type or make. It can be installed

Increased number of shares and votes in Karnov Group AB (publ)

As of today, 30 June 2022, the total number of shares and votes in Karnov Group AB (publ) amounts to 108,102,047 shares and 107,872,208.6 votes.During the month of June 2022, 169,971 shares of series C, previously issued and repurchased under Karnov Group’s long-term incentive plan resolved by an extraordinary general meeting in April 2019 (LTIP 2019), were converted into ordinary shares. The number of ordinary shares has thus increased by 169,971 shares and the number of Class C shares has decreased by the same number of shares. The number of votes has increased by 152,973.9. The total

Increased number of shares and voting rights in Catena Media plc

Catena Media plc announces that the number of shares and voting rights in the company has increased by 6,696 due to the exercise of Catena Media’s warrants (CTM TO1) during the ninth warrant exercise period that followed publication of the interim report for the first quarter of 2022. As announced on 3 June, 6,696 warrants were used to subscribe for the same number of new ordinary shares in Catena Media during the ninth warrant exercise period. The new shares were then registered with the Maltese authorities.  As of today, the last trading day of the month, the number of shares and

Nomination committee at MAG Interactive AB (publ) for the Annual General Meeting 2023

Nomination committee appointed at MAG Interactive for the Annual General Meeting 2023.Stockholm, Sweden - 30 June, 2022 - As per April 30th the largest shareholders in MAG Interactive AB (publ) were CEO Daniel Hasselberg (through NMO Invest AB) and the following four parties were Kaj Nygren (through Playful Days AB), Avanza Pension, Didner & Gerge Fonder and Swedbank Robur Fonder. The nomination committee for the MAG Interactive AB (publ) Annual General Meeting 2023: Joachim Spetz - representing Swedbank Robur FonderHenrik Sandell - representing Didner & Gerge FonderKaj Nygren -

Hansa Biopharma to host conference call to provide half year results for January-June 2022 and Business Update

Lund, Sweden June 30, 2022 Hansa Biopharma AB (Nasdaq Stockholm: HNSA) will publish its interim report for January-June 2022 at 8:00 CET on July 19, 2022. All interested parties are invited to participate in a telephone conference, which will include a presentation of the interim results and a business update, on the same date at 14:00 CET/8:00am EST. The event will be hosted by Hansa Biopharma’s CEO, Søren Tulstrup, and CFO, Donato Spota, and the presentation will be held in English. Slides used in the presentation will be live on the company website during the call under “Events &

Ratos AB – change in number of shares and votes

The last opportunity to convert convertible debentures into shares according to the incentive program for the CEO and other key personnel in Ratos decided on by the 2018 Annual General Meeting was completed in June 2022. Through the conversion, the number of Class B shares increased by 126,604 and the number of votes by 12,660.40. After the increase, the share capital amounts to SEK 1,023,774,217.20.  Before the   After the conversion, no.conversion,no.Class A 84,637,060   Class A shares: 84,637,060shares:Class B 240,244,024   Class

New number of shares and votes in Storskogen Group AB (publ)

The number of shares and votes in Storskogen Group AB (publ), as of today, amounts to 1,663,763,768 shares (of which 148,001,374 A-shares and 1,515,762,394 B-shares) and 2,995,776,134 votes.As previously communicated, the number of shares and votes in Storskogen Group AB (publ) changed in June due to the directed share issue of 3,690,344 B-shares to the sellers of Thermica AS on 31 May 2022. The share issue was registrered with the Swedish Companies Registration Office on 3 June 2022.

There are no items matching the current filter
There are no more items matching the current filter
Back to top